APA (7th ed.) Citation

MY, W., EJ, C., R, H., HV, M., S, K., H, T., . . . DLV, B. (2022). WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed. Lancet (London, England), 400(10369), 2193. https://doi.org/10.1016/S0140-6736(22)01938-9

Chicago Style (17th ed.) Citation

MY, Wu, et al. "WHO's Therapeutics and COVID-19 Living Guideline on MAbs Needs to Be Reassessed." Lancet (London, England) 400, no. 10369 (2022): 2193. https://doi.org/10.1016/S0140-6736(22)01938-9.

MLA (9th ed.) Citation

MY, Wu, et al. "WHO's Therapeutics and COVID-19 Living Guideline on MAbs Needs to Be Reassessed." Lancet (London, England), vol. 400, no. 10369, 2022, p. 2193, https://doi.org/10.1016/S0140-6736(22)01938-9.